期刊
INFLAMMATORY BOWEL DISEASES
卷 20, 期 2, 页码 389-397出版社
OXFORD UNIV PRESS INC
DOI: 10.1097/01.MIB.0000437616.37000.41
关键词
inflammatory bowel disease; cytokines; interleukins
资金
- National Institutes of Health, National Cancer Institute
- Crohn's and Colitis Foundation of America
Inflammatory bowel disease accounts for significant patient morbidity in the Western world. Several immunosuppressive therapies are available but are associated with potential significant adverse effects. In addition, there remains a cohort of patients with refractory or relapsing disease. Therefore, the search for novel therapeutic agents continues. In this review, we evaluate the role of a number of designated cytokines that are candidates in the pathogenesis of inflammatory bowel disease and discuss how their manipulation has been explored as a therapeutic strategy for this disease. The interleukins (ILs) chosen for discussion reflect those that currently show most promise as future therapeutic targets, as well as discussing the role of some of the most recently identified ILs, such as IL-27, IL-33, IL-35, and IL-22, in this context.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据